Many congratulations to Prof Malcolm MacLeod, Consultant Neurologist at Forth Valley Royal Hospital and Prof of Neurology and Translational Neuroscience at the University of Edinburgh, who has been elected as a Fellow of the Academy of Medical Sciences.
The new Fellows have been recognised for their remarkable contributions to biomedical and health science and their ability to generate new knowledge and improve the health of people everywhere.
Professor MacLeod said: “I came to NHS Forth Valley in 2005 as a full time NHS Consultant. I’ve been very fortunate in the support I have had, from colleagues and from management, as I’ve gradually grown the research component of my role. I’ve been a Professor at the University of Edinburgh since 2012, but I’m very glad that I have continued to have a clinical role in Forth Valley and pleased to see others – in the Neurology service and elsewhere – follow in my footsteps.
“I’m delighted to have been elected to Fellowship of the Academy of Medical Sciences, and I think this is in recognition of the work of a whole team of researchers, as we try to provide tools to help every researcher – in the lab or in the clinic – improve the way they go about their research. I hope this recognition will give even greater force to these efforts. At the end of the day, it’s all about delivering better treatments for patients – and the better we are at doing research, the faster this will happen.”
Suvankar Pal, Clinical lead for Neurology, said: “This is extremely well deserved. Malcolm’s leadership and clinical approach have been inspirational to us all. His research has been transformative and made a real difference to the lives of people we do our best to help each day.”
Professor Dame Anne Johnson PMedSci, President of the Academy of Medical Sciences said: “Each of the new Fellows has made important contributions to the health of our society, with a breadth of expertise ranging from the physical and mental health of young people to parasitic diseases and computational biology.
“The diversity of biomedical and health expertise within our Fellowship is a formidable asset that in the past year has informed our work on critical issues such as tackling the COVID-19 pandemic, understanding the health impacts of climate change, addressing health inequalities, and making the case for funding science.”
The new Fellows will be formally admitted to the Academy at the end of June 2022.
